Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits

Kefei Cui, Xiao Ma, Lie Yu, Chao Jiang, Chao Fu, Xiaojie Fu, Xiaofang Yu, Yuanjing Huang, Suyun Hou, Caifeng Si, Zhengguang Chen, Jing Yu, Jieru Wan, Jian Wang

Research output: Contribution to journalArticle

Abstract

Bone marrow mononuclear cells (BMMNCs) can counteract oxidative stress and inhibit the inflammatory response in focal ischemic stroke models. However, the effect of BMMNC transplantation on carotid atherosclerosis needs to be determined. The carotid atherosclerotic plaque model was established in New Zealand White rabbits by balloon injury and 8 weeks of high-fat diet. Rabbits were randomized to receive an intravenous injection of autologous bromodeoxyuridine (BrdU)-labeled BMMNCs or an equal volume of phosphate-buffered saline. Plaques were evaluated for expression of proinflammatory and anti-inflammatory cytokines, anti-oxidant proteins, and markers of cell death. BMMNCs migrated into atherosclerotic plaque on the first day after cell transplantation. BMMNC-treated rabbits had smaller plaques and more collagen deposition than did the vehicle-treated controls on day 28 (p <0.05). BMMNC treatment significantly increased endothelial nitric oxide synthase and the anti-oxidant enzymes glutathione peroxidase and superoxide dismutase in plaques compared to vehicle treatment on day 7. BMMNC-treated rabbits also had lower levels of cleaved caspase-3 expression; lower levels of proinflammatory cytokines interleukin-1β, tumor necrosis factor alpha, and matrix metalloproteinase 9; and higher levels of insulin-like growth factor-1 and its receptor (p <0.05). Autologous BMMNC transplantation can suppress the process of atherosclerotic plaque formation and is associated with enhanced anti-oxidative effect, reduced levels of inflammatory cytokines and cleaved caspase-3, and increased expression of insulin-like growth factor-1 and its receptor. BMMNC transplantation represents a novel approach for the treatment of carotid atherosclerosis.

Original languageEnglish (US)
JournalMolecular Neurobiology
DOIs
StateAccepted/In press - Aug 2 2015

Fingerprint

Carotid Artery Diseases
Bone Marrow Transplantation
Bone Marrow Cells
Rabbits
Atherosclerotic Plaques
Somatomedins
Cytokines
Oxidants
Caspase 3
Nitric Oxide Synthase Type III
Cell Transplantation
Matrix Metalloproteinase 9
High Fat Diet
Bromodeoxyuridine
Glutathione Peroxidase
Interleukin-1
Intravenous Injections
Superoxide Dismutase
Oxidative Stress
Cell Death

Keywords

  • Atherosclerosis
  • Bone marrow mononuclear cell
  • Inflammatory
  • Insulin-like growth factor
  • Oxidative stress

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits. / Cui, Kefei; Ma, Xiao; Yu, Lie; Jiang, Chao; Fu, Chao; Fu, Xiaojie; Yu, Xiaofang; Huang, Yuanjing; Hou, Suyun; Si, Caifeng; Chen, Zhengguang; Yu, Jing; Wan, Jieru; Wang, Jian.

In: Molecular Neurobiology, 02.08.2015.

Research output: Contribution to journalArticle

Cui, K, Ma, X, Yu, L, Jiang, C, Fu, C, Fu, X, Yu, X, Huang, Y, Hou, S, Si, C, Chen, Z, Yu, J, Wan, J & Wang, J 2015, 'Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits', Molecular Neurobiology. https://doi.org/10.1007/s12035-015-9347-3
Cui, Kefei ; Ma, Xiao ; Yu, Lie ; Jiang, Chao ; Fu, Chao ; Fu, Xiaojie ; Yu, Xiaofang ; Huang, Yuanjing ; Hou, Suyun ; Si, Caifeng ; Chen, Zhengguang ; Yu, Jing ; Wan, Jieru ; Wang, Jian. / Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits. In: Molecular Neurobiology. 2015.
@article{439acb7741084ac4a56f058540089210,
title = "Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits",
abstract = "Bone marrow mononuclear cells (BMMNCs) can counteract oxidative stress and inhibit the inflammatory response in focal ischemic stroke models. However, the effect of BMMNC transplantation on carotid atherosclerosis needs to be determined. The carotid atherosclerotic plaque model was established in New Zealand White rabbits by balloon injury and 8 weeks of high-fat diet. Rabbits were randomized to receive an intravenous injection of autologous bromodeoxyuridine (BrdU)-labeled BMMNCs or an equal volume of phosphate-buffered saline. Plaques were evaluated for expression of proinflammatory and anti-inflammatory cytokines, anti-oxidant proteins, and markers of cell death. BMMNCs migrated into atherosclerotic plaque on the first day after cell transplantation. BMMNC-treated rabbits had smaller plaques and more collagen deposition than did the vehicle-treated controls on day 28 (p <0.05). BMMNC treatment significantly increased endothelial nitric oxide synthase and the anti-oxidant enzymes glutathione peroxidase and superoxide dismutase in plaques compared to vehicle treatment on day 7. BMMNC-treated rabbits also had lower levels of cleaved caspase-3 expression; lower levels of proinflammatory cytokines interleukin-1β, tumor necrosis factor alpha, and matrix metalloproteinase 9; and higher levels of insulin-like growth factor-1 and its receptor (p <0.05). Autologous BMMNC transplantation can suppress the process of atherosclerotic plaque formation and is associated with enhanced anti-oxidative effect, reduced levels of inflammatory cytokines and cleaved caspase-3, and increased expression of insulin-like growth factor-1 and its receptor. BMMNC transplantation represents a novel approach for the treatment of carotid atherosclerosis.",
keywords = "Atherosclerosis, Bone marrow mononuclear cell, Inflammatory, Insulin-like growth factor, Oxidative stress",
author = "Kefei Cui and Xiao Ma and Lie Yu and Chao Jiang and Chao Fu and Xiaojie Fu and Xiaofang Yu and Yuanjing Huang and Suyun Hou and Caifeng Si and Zhengguang Chen and Jing Yu and Jieru Wan and Jian Wang",
year = "2015",
month = "8",
day = "2",
doi = "10.1007/s12035-015-9347-3",
language = "English (US)",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",

}

TY - JOUR

T1 - Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits

AU - Cui, Kefei

AU - Ma, Xiao

AU - Yu, Lie

AU - Jiang, Chao

AU - Fu, Chao

AU - Fu, Xiaojie

AU - Yu, Xiaofang

AU - Huang, Yuanjing

AU - Hou, Suyun

AU - Si, Caifeng

AU - Chen, Zhengguang

AU - Yu, Jing

AU - Wan, Jieru

AU - Wang, Jian

PY - 2015/8/2

Y1 - 2015/8/2

N2 - Bone marrow mononuclear cells (BMMNCs) can counteract oxidative stress and inhibit the inflammatory response in focal ischemic stroke models. However, the effect of BMMNC transplantation on carotid atherosclerosis needs to be determined. The carotid atherosclerotic plaque model was established in New Zealand White rabbits by balloon injury and 8 weeks of high-fat diet. Rabbits were randomized to receive an intravenous injection of autologous bromodeoxyuridine (BrdU)-labeled BMMNCs or an equal volume of phosphate-buffered saline. Plaques were evaluated for expression of proinflammatory and anti-inflammatory cytokines, anti-oxidant proteins, and markers of cell death. BMMNCs migrated into atherosclerotic plaque on the first day after cell transplantation. BMMNC-treated rabbits had smaller plaques and more collagen deposition than did the vehicle-treated controls on day 28 (p <0.05). BMMNC treatment significantly increased endothelial nitric oxide synthase and the anti-oxidant enzymes glutathione peroxidase and superoxide dismutase in plaques compared to vehicle treatment on day 7. BMMNC-treated rabbits also had lower levels of cleaved caspase-3 expression; lower levels of proinflammatory cytokines interleukin-1β, tumor necrosis factor alpha, and matrix metalloproteinase 9; and higher levels of insulin-like growth factor-1 and its receptor (p <0.05). Autologous BMMNC transplantation can suppress the process of atherosclerotic plaque formation and is associated with enhanced anti-oxidative effect, reduced levels of inflammatory cytokines and cleaved caspase-3, and increased expression of insulin-like growth factor-1 and its receptor. BMMNC transplantation represents a novel approach for the treatment of carotid atherosclerosis.

AB - Bone marrow mononuclear cells (BMMNCs) can counteract oxidative stress and inhibit the inflammatory response in focal ischemic stroke models. However, the effect of BMMNC transplantation on carotid atherosclerosis needs to be determined. The carotid atherosclerotic plaque model was established in New Zealand White rabbits by balloon injury and 8 weeks of high-fat diet. Rabbits were randomized to receive an intravenous injection of autologous bromodeoxyuridine (BrdU)-labeled BMMNCs or an equal volume of phosphate-buffered saline. Plaques were evaluated for expression of proinflammatory and anti-inflammatory cytokines, anti-oxidant proteins, and markers of cell death. BMMNCs migrated into atherosclerotic plaque on the first day after cell transplantation. BMMNC-treated rabbits had smaller plaques and more collagen deposition than did the vehicle-treated controls on day 28 (p <0.05). BMMNC treatment significantly increased endothelial nitric oxide synthase and the anti-oxidant enzymes glutathione peroxidase and superoxide dismutase in plaques compared to vehicle treatment on day 7. BMMNC-treated rabbits also had lower levels of cleaved caspase-3 expression; lower levels of proinflammatory cytokines interleukin-1β, tumor necrosis factor alpha, and matrix metalloproteinase 9; and higher levels of insulin-like growth factor-1 and its receptor (p <0.05). Autologous BMMNC transplantation can suppress the process of atherosclerotic plaque formation and is associated with enhanced anti-oxidative effect, reduced levels of inflammatory cytokines and cleaved caspase-3, and increased expression of insulin-like growth factor-1 and its receptor. BMMNC transplantation represents a novel approach for the treatment of carotid atherosclerosis.

KW - Atherosclerosis

KW - Bone marrow mononuclear cell

KW - Inflammatory

KW - Insulin-like growth factor

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84938614564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938614564&partnerID=8YFLogxK

U2 - 10.1007/s12035-015-9347-3

DO - 10.1007/s12035-015-9347-3

M3 - Article

C2 - 26232064

AN - SCOPUS:84938614564

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -